Reimagining Pharma Batch Analysis with Mareana CMC
/ Modernize Batch Analysis

Reimagining Pharma Batch Analysis with Mareana CMC

Reimagining Pharma Batch Analysis with Mareana CMC
  • Reduce manual effort associated with batch record management
  • Strengthen regulatory compliance and audit readiness
  • Standardize data management across manufacturing operations

Smarter CMC Operations

Download the white paper

By submitting your details, you agree to our Privacy Policy , and to receive email communications from Mareana. You may unsubscribe at any time.

Key Takeaways

With Mareana, you can transform paper-based batch records into connected, searchable manufacturing data that improves compliance, analysis, and operational efficiency.

In this whitepaper, you will learn
  • Why paper-based batch record management creates operational challenges

  • Best practices for digitizing and validating manufacturing records

  • Ways analytics can enhance batch analysis and process visibility

  • The role of Mareana CMC in modern pharmaceutical manufacturing

Good Manufacturing
Practice

Connected Data Deep Insights.

Good Manufacturing
Practice

Connected Data Deep Insights.

/ ANY QUESTIONS? WE'D LOVE TO HELP

Frequently Asked Questions

Digital CMC (Chemistry, Manufacturing, and Controls) software helps pharmaceutical companies digitize batch records, automate compliance processes, and streamline manufacturing operations. By replacing paper-based systems, digital CMC solutions improve data accuracy, reduce errors, and accelerate product approvals while ensuring regulatory compliance.

Digital CMC software centralizes batch data from multiple sources, enabling real-time pharma batch analysis through advanced analytics and automated reporting. This helps manufacturers identify trends, resolve deviations faster, improve product quality, and make data-driven decisions across the manufacturing lifecycle.

Automating pharmaceutical batch records reduces manual data entry, minimizes transcription errors, improves regulatory compliance, and speeds up batch review and release processes. It also enhances operational efficiency, lowers investigation time, and supports faster time-to-market for pharmaceutical products.

Modern digital CMC platforms include built-in compliance controls, audit trails, electronic signatures, and automated validation processes that support FDA, EMA, and 21 CFR Part 11 requirements. These features help pharmaceutical manufacturers maintain consistent compliance and reduce regulatory risks.

Yes. Digital CMC solutions help reduce operational costs by automating repetitive tasks, minimizing production downtime, reducing compliance-related workload, and improving process efficiency. Organizations can also decrease investigation efforts and accelerate product release timelines, resulting in significant cost savings.

When selecting a digital CMC platform, pharmaceutical companies should look for:

  • Batch record digitization and management
  • Advanced analytics and reporting
  • Automated compliance monitoring
  • Cloud scalability and flexibility
  • Data security and encryption
  • CFR Part 11 compliance
  • Seamless integration with existing manufacturing systems

These capabilities help ensure efficient pharma batch analysis, regulatory compliance, and long-term operational excellence.

8 AI use cases to transform your quality assurance.
/ BEFORE YOU GO

8 AI use cases to transform your quality assurance.

By signing up, you agree to the Privacy Policy.